Mike Clarke

Mike Clarke has made 26 investments in companies such as: Txt4, Mirifice, Andel, Radio Waves, CellTran, Diamond Microwave Devices, ProVision Communications, REM ENTERPRISE, Object Matrix, CMS Global Technologies, 2sms, Covalent Software, eflow, Aupix, Aconite Technology, Dynmark International, Break30, PDD Group, Conversity Ltd, New Net Technologies, Paraytec, Mtivity, Pro-Cure Therapeutics, Lattice Voice Technologies, TBi Connect, GO-SIM.

Location of Mike Clarke is Leeds, United Kingdom.

The free version of Angel Match provides limited data for Mike Clarke. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Mike Clarke is a Investment Director and he his investment types are: Private Equity Firm, Venture Capital.
Mike Clarke focuses investing in industries such as: Biotechnology, Health Diagnostics, Medical, Pharmaceutical, Compliance, Information Technology, Security, Software, Electronics, Manufacturing, Semiconductor, Automotive, Mobile, Hardware, Sports, Messaging, Telecommunications.

A short brief about investor:


Past investments

  • Txt4
  • Mirifice
  • Andel
  • Radio Waves
  • CellTran
  • Diamond Microwave Devices
  • ProVision Communications
  • Object Matrix
  • CMS Global Technologies
  • 2sms
  • Covalent Software
  • eflow
  • Aupix
  • Aconite Technology
  • Dynmark International
  • Break30
  • PDD Group
  • Conversity Ltd
  • New Net Technologies
  • Paraytec
  • Mtivity
  • Pro-Cure Therapeutics
  • Lattice Voice Technologies
  • TBi Connect
  • GO-SIM

Social media:

Available after registration.